| RS2147914963 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147914987 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2147915059 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary leiomyomatosis and renal cell cancer |
| RS2147916020 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Colon adenocarcinoma |
| RS2147916135 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147916185 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2147916256 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2147916281 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147916319 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2147916324 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147916327 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147916371 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2147916393 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147916407 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147916471 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2147916480 |
CACNA1F
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 3, X-linked cone-rod dystrophy 3 |
| RS2147916504 |
CACNA1F
|
Health Risk |
Pathogenic |
X-linked cone-rod dystrophy 3, X-linked cone-rod dystrophy 3 |
| RS2147916854 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147917520 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147917609 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147917619 |
FH
|
Health Risk |
Pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2147917894 |
CACNA1F
|
Health Risk |
Likely pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS2147919032 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147919372 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147919380 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147919385 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147919403 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147919465 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2147919525 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147919590 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147919608 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147919703 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147919711 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary leiomyomatosis and renal cell cancer, Hereditary cancer-predisposing syndrome |
| RS2147921052 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Becker muscular dystrophy |
| RS2147921112 |
CACNA1F
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2147921624 |
AKT3
|
Health Risk |
Pathogenic |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 |
| RS2147921662 |
AKT3
|
Health Risk |
Likely pathogenic |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 |
| RS2147921728 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147921791 |
CACNA1F
|
Health Risk |
Pathogenic |
— |
| RS2147921795 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2147921868 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2147921876 |
FH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147921886 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147921891 |
FH
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2147921966 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147922022 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147922731 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2147922924 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary leiomyomatosis and renal cell cancer, Hereditary leiomyomatosis and renal cell cancer |
| RS2147923081 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147923117 |
FH
|
Health Risk |
Likely pathogenic |
— |
| RS2147923128 |
ORC1
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome 1, Meier-Gorlin syndrome 1 |
| RS2147923995 |
TEX11
|
Health Risk |
Pathogenic |
Non-obstructive azoospermia, Non-obstructive azoospermia |
| RS2147924133 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2147924614 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2147925168 |
FH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147925227 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2147925559 |
CACNA1F
|
Health Risk |
Likely pathogenic |
— |
| RS2147926843 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147926875 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147926893 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147926916 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147926966 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147927054 |
FH
|
Health Risk |
Pathogenic |
— |
| RS2147927599 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2147928664 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2147933505 |
SYN1
|
Health Risk |
Pathogenic |
Epilepsy, X-linked 1 |
| RS2147933547 |
SYN1
|
Health Risk |
Likely pathogenic |
— |
| RS2147933949 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147934341 |
PHKA2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXa1, Glycogen storage disease IXa1 |
| RS2147934458 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2147934840 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147934967 |
COL4A5
|
Health Risk |
Pathogenic |
— |
| RS2147935042 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147935344 |
COL4A5
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS2147935387 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2147935442 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147935467 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS2147935982 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2147936347 |
DMD
|
Health Risk |
Pathogenic/Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2147938135 |
CCDC22
|
Health Risk |
Conflicting classifications of pathogenicity |
Ritscher-Schinzel syndrome 2, Ritscher-Schinzel syndrome 2 |
| RS2147939390 |
MTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylcobalamin deficiency type cblG, Inborn genetic diseases |
| RS2147940284 |
PCNT
|
Health Risk |
Pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2147941262 |
ORC1
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome 1, Meier-Gorlin syndrome 1 |
| RS2147942943 |
ORC1
|
Health Risk |
Pathogenic |
— |
| RS2147944039 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147944106 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147944159 |
FOXP3
|
Health Risk |
Likely pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147944334 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS2147944391 |
FOXP3
|
Health Risk |
Pathogenic |
Insulin-dependent diabetes mellitus secretory diarrhea syndrome, Insulin-dependent diabetes mellitus secretory diarrhea syndrome |
| RS2147944830 |
KIDINS220
|
Health Risk |
Likely pathogenic |
Cerebral palsy, Cerebral palsy |
| RS2147944895 |
GJB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Peripheral neuropathy, Peripheral neuropathy |
| RS2147945283 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147945425 |
KIDINS220
|
Health Risk |
Pathogenic |
Spastic paraplegia, intellectual disability |
| RS2147945432 |
GJB1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS2147945443 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147945457 |
KIDINS220
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, intellectual disability |
| RS2147945607 |
GJB1
|
Health Risk |
Pathogenic |
— |
| RS2147945660 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147945690 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS2147945805 |
NBAS
|
Health Risk |
Pathogenic |
— |